Monday, August 16, 2010

SANEVAX Team Continues The Focus ON Human Papillomavirus (HPV) Monitoring Test For HPV Vaccine Users


SANEVAX Team Continues The Focus on Human Papillomavirus (HPV) Monitoring Test For HPV Vaccine Users



NORTH HOLLYWOOD, CA, August 16, 2010  SaneVax, Inc., http://sanevax.org, is a non-profit organization, founded to offer affordable highly sensitive HPV testing with specific genotyping by DNA sequencing, for pre- and post vaccination.

According to Chairman of the board, Norma Erickson, the SaneVax mission is to promote Safe, Affordable, Necessary &Effective vaccines and vaccination practices through education and information.

Other organization members include, Leslie Carol Botha, Women’s Health Educator and broadcast journalist; Rosemary Mathis, mother of a daughter injured by the Gardasil vaccination; Freda Birrell, political lobbyist in the UK and Scotland and Janny Stokvis, vaccine researcher. The five women have spearheaded this effort to provide a web site with research articles, studies and data not only on the HPV vaccines - but on eventually on all vaccines marketed in the United States.

Erickson states that the SaneVax team believes in science-based medicine. The primary goal of the organization is to provide the information necessary to assist in making informed decisions regarding vaccination choices. The organization also provides resource referrals to vaccine-injury physicians, medical practitioners, attorneys, and other vaccine-related groups for those unfortunate enough to have experienced vaccine-related injuries.

SANE VAX Inc. will be offering Human papillomavirus (HPV) monitoring test for HPV vaccine users, and will be working in conjunction with Dr. Sin Hang Lee F.R.C.P. (C), FCAP. Dr. Lee has over 50 years’ experience in general/surgical pathology and clinical microbiology and is authorized to practice in the U.S., Canada, and the U.K. Dr. Lee is particularly concerned about the health issues surrounding the HPV vaccines.

There are 283 cases of post-vaccination abnormal pap smears reported to the Vaccine Event Reporting System (VAERS) with more reports of high-risk HPV, cervical lesions and cervical cancer beginning to surface in medical journals.

According to Dr. Lee’s research, HPV 16, one of the two strains of the virus targeted by Gardasil, is not even prevalent in the U.S. HPV 32, 18 and 58 are common strains in some parts of the U.S., but this varies from one location to the next. Lee has also noted that it is a persistent infection with HPV strains that may lead to cervical cancer - not just a onetime exposure. He is quick to emphasize that the virus usually passes through women’s bodies within four menstrual cycles.

Pre-testing for HPV is crucial since the May 2008 FDA VRBPAC documents have noted that exposure to HPV prior to vaccination raises the risk of cervical cancer 44.6% for Gardasil and 32.5% for Cervarix. Post-vaccination testing is equally important for those who have suffered adverse reactions to the vaccine.

“Pre and post HPV testing is crucial to identify whether a young woman has already been exposed to HPV - and to try and understand the mechanisms of action causing the injury and death of innocent girls after inoculation,” states Botha. Parents are already expressing interest in HPV testing which costs $50 per test through a national specialty clinical laboratory. Most health insurance companies will reimburse the cost.

The SaneVax site provides the latest news on vaccines, including those currently being developed and tested, with links to scientific studies on their potential safety, efficacy and need. The site also includes a blog, videos, several discussion forums and a physicians’ forum, where doctors representing various medical disciplines, and successfully treating vaccine injuries, can collaborate with each other.

For more information email info@sanevax.org.

Contact Information
Bobbie Cowan
Title: Owner
Bobbi Cowan Public Relations
North Hollywood, CA
 
Phone: (818) 980-2372

Email:
 bobbicowan@sbcglobal.net
Visit Website

The SANE Vax Mission is to promote Safe, Affordable, Necessary & Effective vaccines and vaccination practices through education and information. We believe in science-based medicine. Our primary goal is to provide the information necessary for you to make informed decisions regarding your health and well-being. We also provide referrals to helpful resources for those unfortunate enough to have experienced vaccine-related injuries.

Adverse events experienced after HPV vaccines have brought the issue of vaccine safety to the forefront around the world. S.A.N.E. VAX, Inc. is a place to find the answers to questions you may have regarding vaccine safety and efficacy
;
S.A.N.E. VAX, Inc. is a non-profit organization established to provide a single site for information to help you:
1.   Obtain the information you need to make informed decisions prior to vaccination;

2.   Locate appropriate medical/legal assistance if you, or a loved one, suffers from a serious adverse event after vaccination.

The S.A.N.E. VAX, Inc. website provides the latest news on vaccines, including those currently being developed and tested, with links to scientific studies on their potential safety, efficacy and need. Our intent is to cover the vaccine issue on a global scale.

S.A.N.E. VAX, Inc. provides links to vaccine-injury physicians and medical practitioners, vaccine-injury attorneys, and other vaccine-related groups. We will provide instructions on how to become politically active, should you wish to do so, along with links to political vaccine action groups representing thousands of victims.
S.A.N.E. VAX, Inc. has a physicians’ forum, where doctors representing various medical disciplines, and successfully treating vaccine injuries, can collaborate with each other.

S.A.N.E. VAX, Inc. offers a blog and several forum discussions where you can communicate with others who have similar concerns. Have a specific question?  Post it on the S.A.N.E. VAX, Inc. forum and our team will respond.  If we do not have the answer, we will find the professional who does.

No comments: